Last reviewed · How we verify
NCT03822429
Cumulative Live Birth Rate (CLBR) After a Complete IVF Cycle: a Single Center Retrospective Study
trial testing Controlled ovarian stimulation in ART in 6,375 participants. Completed in 31 December 2015.
31 December 2015
Quick facts
| Lead sponsor | Istituto Clinico Humanitas |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 6,375 |
| Start date | 1 January 2010 |
| Primary completion | 31 December 2015 |
| Estimated completion | 31 December 2015 |
Drugs / interventions tested
- Controlled ovarian stimulation — full drug profile →
Conditions studied
- ART — all drugs for ART →
- Fertility Disorders — all drugs for Fertility Disorders →
Sponsor
Istituto Clinico Humanitas
Who can join
Adults 18 to 46, female only, with ART or Fertility Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
We need to identify a new parameter to evaluate the success rate of IVF techniques. CLBR has been suggested as a suitable way for reporting success of IVF program: it implies capturing the totality of live birth episodes following successive treatments. For patients CLBR is easy to understand because it summarizes the chance of a live birth over an entire treatment period. CLBR per oocyte retrieval is more meaningful as it is the best indicator of quality and success in IVF and it allows the best indicator of quality and success in IVF with different strategies for freezing embryos.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03822429
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ART
Currently open trials in the same condition.
- NCT07278960 — Enhancing Management Algorithms for Children Conceived Via Assisted Reproductive Technologies · recruiting
- NCT06484335 — RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV · Phase 1 · recruiting
- NCT07263490 — PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) · recruiting
- NCT06334003 — Cardiometabolic Function in Offspring, Mother and Placenta After Assisted Reproductive Technology · recruiting
- NCT06374758 — Accelerated ART Initiation for PWHIV Who Are Out of Care · Phase 4 · recruiting
Other Istituto Clinico Humanitas trials
Trials by the same sponsor.
- NCT06944288 — Microbiota as Early Diagnostic and predictivE Factor for Osteoarthritic Degeneration and Microbial Contamination · NA · not yet recruiting
- NCT07358247 — Postoperative Outcomes of Single-stapled Anastomosis Combined With Transanal Natural Orifice Specimen Extraction · not yet recruiting
- NCT07362342 — RIght VEntricle Response to Major Lung Resection in VATS and Robotic Surgery · not yet recruiting
- NCT07346274 — Intra-operative Hypotension and Post-operative Lactate Level After Pancreatic-duodenectomy. · enrolling by invitation
- NCT07491419 — The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03822429 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istituto Clinico Humanitas
- Last refreshed: 30 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03822429.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing